Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection

NCT03512210 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

400

Enrollment

NETWORK

Sponsor class

Conditions

Hepatitis C
HIV-1-infection
Liver Diseases

Interventions

DRUG: Sofosbuvir/Velpatasvir (SOF/VEL)
OTHER: Minimal Monitoring (MINMON) Strategy

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborators

[object Object]